Norbert Weißmann

27.5k total citations · 7 hit papers
375 papers, 19.7k citations indexed

About

Norbert Weißmann is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Norbert Weißmann has authored 375 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Pulmonary and Respiratory Medicine, 123 papers in Physiology and 119 papers in Molecular Biology. Recurrent topics in Norbert Weißmann's work include Pulmonary Hypertension Research and Treatments (180 papers), Nitric Oxide and Endothelin Effects (94 papers) and Neuroscience of respiration and sleep (42 papers). Norbert Weißmann is often cited by papers focused on Pulmonary Hypertension Research and Treatments (180 papers), Nitric Oxide and Endothelin Effects (94 papers) and Neuroscience of respiration and sleep (42 papers). Norbert Weißmann collaborates with scholars based in Germany, United States and United Kingdom. Norbert Weißmann's co-authors include Werner Seeger, Friedrich Grimminger, Ralph T. Schermuly, Hossein Ardeschir Ghofrani, Ralf P. Brandes, Katrin Schröder, Frank Rose, Soni Savai Pullamsetti, Horst Olschewski and David G. Harrison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Norbert Weißmann

367 papers receiving 19.4k citations

Hit Papers

Cellular and Molecular Basis of Pulmonary Arterial Hypert... 2002 2026 2010 2018 2009 2003 2014 2002 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cellular and Molecular Basis of Pulmonary Arterial Hypertension
    2009 640 citations Norbert Weißmann et al. profile →
  2. Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols
    2003 560 citations Norbert Weißmann et al. profile →
  3. Nox family NADPH oxidases: Molecular mechanisms of activation
    2014 555 citations Ralf P. Brandes, Norbert Weißmann et al. profile →
  4. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
    2002 537 citations Hossein Ardeschir Ghofrani, Frank Rose et al. profile →
  5. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
    2012 510 citations Katrin Schröder, Min Zhang et al. Circulation Research profile →
  6. Pulmonary hypertension in chronic lung disease and hypoxia
    2018 428 citations Joan Albert Barberà, Horst Olschewski et al. European Respiratory Journal profile →
  7. Pulmonary Hypertension: A Contemporary Review
    2023 69 citations Natascha Sommer, Norbert Weißmann et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Weißmann Germany 72 10.1k 6.1k 5.0k 4.8k 2.2k 375 19.7k
Ralph T. Schermuly Germany 72 13.8k 1.4× 5.8k 0.9× 6.2k 1.2× 3.2k 0.7× 1.3k 0.6× 397 20.0k
Kenneth D. Bloch United States 75 4.8k 0.5× 6.4k 1.0× 5.7k 1.1× 6.0k 1.2× 1.2k 0.5× 264 18.6k
Evangelos D. Michelakis Canada 67 8.0k 0.8× 7.5k 1.2× 5.0k 1.0× 2.9k 0.6× 616 0.3× 150 17.0k
Duncan J. Stewart Canada 70 6.6k 0.7× 5.6k 0.9× 6.3k 1.3× 3.8k 0.8× 1.2k 0.6× 345 19.3k
Toshiro Fujita Japan 97 3.9k 0.4× 13.8k 2.3× 5.2k 1.0× 4.4k 0.9× 2.3k 1.0× 706 38.5k
Serge Adnot France 65 8.0k 0.8× 2.9k 0.5× 3.7k 0.7× 2.8k 0.6× 697 0.3× 215 12.4k
Holger K. Eltzschig United States 88 3.5k 0.4× 7.9k 1.3× 2.9k 0.6× 2.5k 0.5× 4.4k 2.0× 290 27.3k
Fumiaki Marumo Japan 89 4.9k 0.5× 13.4k 2.2× 7.3k 1.4× 6.4k 1.3× 1.3k 0.6× 626 28.0k
Hiroshi Itoh Japan 74 2.5k 0.2× 9.2k 1.5× 6.8k 1.4× 3.9k 0.8× 1.1k 0.5× 609 22.7k
Philip W. Shaul United States 69 3.0k 0.3× 5.4k 0.9× 2.9k 0.6× 4.1k 0.8× 2.0k 0.9× 211 18.7k

Countries citing papers authored by Norbert Weißmann

Since Specialization
Citations

This map shows the geographic impact of Norbert Weißmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Weißmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Weißmann more than expected).

Fields of papers citing papers by Norbert Weißmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Weißmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Weißmann. The network helps show where Norbert Weißmann may publish in the future.

Co-authorship network of co-authors of Norbert Weißmann

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Weißmann. A scholar is included among the top collaborators of Norbert Weißmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Weißmann. Norbert Weißmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seidel, Laurence, Caroline Smith, Natascha Sommer, et al.. (2024). Death-associated protein kinase 1 prevents hypoxia-induced metabolic shift and pulmonary arterial smooth muscle cell proliferation in PAH. Cellular Signalling. 127. 111527–111527. 1 indexed citations
2.
Giordano, Luca, Manish K. Aneja, Natascha Sommer, et al.. (2021). Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active. Gene Therapy. 29(12). 655–664. 8 indexed citations
3.
Blanco, Isabel, Gábor Kovács, Zsuzsanna Helyes, et al.. (2020). Pulmonary hypertension in chronic obstructive pulmonary disease. British Journal of Pharmacology. 178(1). 132–151. 60 indexed citations
4.
Pullamsetti, Soni Savai, Argen Mamazhakypov, Norbert Weißmann, Werner Seeger, & Rajkumar Savai. (2020). Hypoxia-inducible factor signaling in pulmonary hypertension. Journal of Clinical Investigation. 130(11). 5638–5651. 150 indexed citations
5.
Moreno‐Domínguez, Alejandro, Patricia Ortega‐Sáenz, Lin Gao, et al.. (2020). Acute O 2 sensing through HIF2α-dependent expression of atypical cytochrome oxidase subunits in arterial chemoreceptors. Science Signaling. 13(615). 71 indexed citations
6.
Giordano, Luca, Laura Salminen, Robert Voswinckel, et al.. (2018). Alternative Oxidase Attenuates Cigarette Smoke–induced Lung Dysfunction and Tissue Damage. American Journal of Respiratory Cell and Molecular Biology. 60(5). 515–522. 36 indexed citations
7.
Olschewski, Andrea, Eva Berghausen, Christina A. Eichstaedt, et al.. (2018). Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 4–10. 26 indexed citations
8.
Budas, Grant R., Mario Boehm, Baktybek Kojonazarov, et al.. (2017). ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 197(3). 373–385. 77 indexed citations
9.
Pullamsetti, Soni Savai, Ralph T. Schermuly, Hossein Ardeschir Ghofrani, et al.. (2014). Novel and Emerging Therapies for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 189(4). 394–400. 61 indexed citations
10.
Veith, Christine, Beate Fuchs, Katharina Hofmann, et al.. (2013). Classical Transient Receptor Potential Channel 1 in Hypoxia-induced Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 188(12). 1451–1459. 70 indexed citations
11.
Schröder, Katrin, Min Zhang, Sebastian Benkhoff, et al.. (2012). Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase. Circulation Research. 110(9). 1217–1225. 510 indexed citations breakdown →
12.
Kwapiszewska, Grażyna, Philipp Markart, Bhola K. Dahal, et al.. (2012). PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension. Circulation Research. 110(9). 1179–1191. 50 indexed citations
13.
Savai, Rajkumar, Soni Savai Pullamsetti, Ewa Bieniek, et al.. (2012). Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(9). 897–908. 308 indexed citations
14.
Dahal, Bhola K., Djuro Kosanovic, Josef Messinger, et al.. (2011). Role of mast cells and chymase in pulmonary vascular remodeling. European Respiratory Journal. 38(Suppl 55). p1524–p1524. 1 indexed citations
15.
Freyhaus, Henrik ten, Markus Dagnell, Marius Vantler, et al.. (2010). Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by Down-Regulation of Protein Tyrosine Phosphatases. American Journal of Respiratory and Critical Care Medicine. 183(8). 1092–1102. 70 indexed citations
16.
Hecker, Matthias, Zbigniew Zasłona, Grażyna Kwapiszewska, et al.. (2010). Dysregulation of the IL-13 Receptor System. A Novel Pathomechanism in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 182(6). 805–818. 55 indexed citations
17.
Rose, Frank, Friedrich Grimminger, Norbert Weißmann, et al.. (2002). Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells‐role of hypoxia‐inducible transcription factors. The FASEB Journal. 16(12). 1660–1661. 90 indexed citations
18.
Schermuly, Ralph T., Christian Schudt, Norbert Weißmann, et al.. (2001). Coaerosolization of Phosphodiesterase Inhibitors Markedly Enhances the Pulmonary Vasodilatory Response to Inhaled Iloprost in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 164(9). 1694–1700. 47 indexed citations
19.
Schermuly, Ralph T., Andreas Günther, Norbert Weißmann, et al.. (2000). Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (V A /Q) Mismatch in a Model of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 161(1). 152–159. 27 indexed citations
20.
Schermuly, Ralph T., Hossein Ardeschir Ghofrani, Beate Enke, et al.. (1999). Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 160(5). 1500–1506. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph T. Schermuly Breakdown of academic impact, for papers by Kenneth D. Bloch Breakdown of academic impact, for papers by Evangelos D. Michelakis Breakdown of academic impact, for papers by Duncan J. Stewart Breakdown of academic impact, for papers by Toshiro Fujita Breakdown of academic impact, for papers by Serge Adnot Breakdown of academic impact, for papers by Holger K. Eltzschig Breakdown of academic impact, for papers by Fumiaki Marumo Breakdown of academic impact, for papers by Hiroshi Itoh Breakdown of academic impact, for papers by Philip W. Shaul
Rankless by CCL
2026